G Sachs: SINOPHARM 2Q Results In Line, Cuts TP to HKD18.46AASTOCKS News·Aug 26 at 06:45 AM01099-0.78%600511-0.53%
Sinopharm H1 net profit drops 2.95% to RMB 5.18 billion; revenue slips 1.13% to RMB 282.8 billionPUBT·Aug 23 at 10:15 PM01099-0.78%600511-0.53%
HBM Holdings enters strategic biologics R&D collaboration with SinopharmPUBT·Jul 27 at 09:00 AM01099-0.78%02142+4.07%
Sinopharm Seeks Shareholder Mandate for Up to 10% H-Share BuybackTip Ranks·May 27 at 10:57 PM600511-0.53%01099-0.78%
Sinopharm subsidiary posts steady Q1 profit growth but cash flow weakensTip Ranks·Apr 22 at 12:45 PM600511-0.53%
Sinopharm Sets April Board Meeting to Approve First-Quarter 2026 ResultsTip Ranks·Apr 10 at 09:10 AM000028-0.45%600511-0.53%
Sinopharm Group Co (SHTDF) Gets a Buy from First Shanghai SecuritiesTip Ranks·Apr 5 at 05:16 AM01099-0.78%159849-1.19%
Shineway Profit Rises Despite Revenue Slump as TCM Sector ResetsTip Ranks·Mar 27 at 04:09 AM512290-0.68%159992-0.71%
SINOPHARM stated that there are no plans for large-scale store closures this year, as health consumption has become a necessityStheadline·Mar 23 at 06:37 AM600511-0.53%000028-0.45%
Sinopharm Defies Industry Headwinds With 2025 Profit Growth and Retail TurnaroundTip Ranks·Mar 22 at 10:37 PM000028-0.45%600511-0.53%
Sinopharm Proposes Final Cash Dividend of RMB 0.69 per Share for 2025Tip Ranks·Mar 22 at 10:37 PM000028-0.45%01069-1.75%
SINOPHARM's subsidiary SINOPHARM(CNCM LTD) earned 1.997 billion RMB for the year, a slight decrease of 0.2%AASTOCKS·Mar 19 at 04:04 PM000028-0.45%588250-0.97%
Sinopharm Subsidiary Posts 2025 Revenue Growth Amid Flat Earnings and Stronger Cash FlowTip Ranks·Mar 19 at 02:11 PM000028-0.45%600056-1.31%
Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities | OSRH Stock NewsStockTitan·Mar 19 at 04:55 AM159849-1.19%562600-1.39%
